4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000012
Chief Operating Officer gave up 1,028 shares (to pay taxes)
- Chief Operating Officer acquired 28,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2023-03-01 | Grant or award | +28,400 | 73,683 | D: show line 1 in the form | ||
| Dowden Nathan J Chief Operating Officer | 2023-03-02 | Shares withheld for taxes | −1,028 | $11.60 | $11,921 | 72,655 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_167787916889742.xml…